One Year of Long-Acting Cabotegravir and Rilpivirine in People With Human Immunodeficiency Virus and Long Exposure to Antiretroviral Therapy: Data From the SCohoLART StudyCamilla Muccini, Antonella Castagna, Tommaso Clemente et al.|Open Forum Infectious Diseases|2024Cited by 20
Increasing incidence and prevalence of metabolic syndrome in people living with HIV during the COVID-19 pandemicRebecka Papaioannu Borjesson, Vincenzo Spagnuolo, Andrea Poli et al.|Frontiers in Medicine|2023Cited by 4
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19Marco Ripa, Ilaria Mainardi, Concetta Vinci et al.|Open Forum Infectious Diseases|2022Cited by 2
Outcomes after a virological failure to first-line second-generation INSTI-based therapy in a real-life settingRebecka Papaioannu Borjesson, Vincenzo Spagnuolo, Camilla Muccini et al.|Journal of Antimicrobial Chemotherapy|2024Cited by 2
Disseminated Mycobacterium chimaera infection favoring the development of Kaposi’s sarcoma: a case reportTommaso Clemente, Anna Danise, Benedetto Del Forno et al.|Annals of Clinical Microbiology and Antimicrobials|2022Cited by 1